Penguin Location Services Announces Breakthrough RTLS 3.0 Platform and Expands Healthcare AI Capabilities for 2026

Next-Generation Real-Time Location System (RTLS) for Healthcare Delivers Enhanced Hospital Safety, Asset Tracking, and Patient Flow Orchestration

IRVINE, Calif., Dec. 16, 2025 /PRNewswire/ — Penguin Location Services, an emerging leader in real-time location systems (RTLS) and AI-driven hospital operations, today announced a year of major product advancements and rapid global adoption as the company prepares for accelerated expansion into the healthcare RTLS market.

Penguin’s disruptive approach, combining BLE 5.1, AI-driven precision, and a true SaaS deployment model, positions the company at the forefront of what industry observers are calling RTLS 3.0—the next evolution of real-time location technology for hospitals and healthcare facilities with a low total cost of ownership. The transition from RTLS 2.0 to RTLS 3.0 can be defined as the transition from “connected tracking” to “intelligent, secure orchestration”, ensuring location and sensory data can be extracted to automate hospital workflows and improve enterprise safety.

Major Technology Breakthroughs Enable the RTLS 3.0 Era for Healthcare

In 2025, Penguin’s proprietary BLE 5.1 location engine achieved significant advancements in sub-room-level accuracy, resiliency, and scalability. These healthcare RTLS capabilities powered large hospital deployments in some of the world’s most demanding environments, demonstrating Penguin’s ability to support enterprise-wide safety and throughput optimization. Key advancements included:

These hospital RTLS solutions enable healthcare facilities to address safety, patient experience, and operational efficiency needs within a single, integrated platform.

Market Opportunity: Replacing Legacy Healthcare RTLS Vendors

As health systems reassess long-standing RTLS deployments, Penguin is positioning itself as the trusted alternative to legacy vendors associated with high costs, proprietary hardware, poor scalability, and eroding customer confidence.

Penguin’s RTLS 3.0 model for healthcare offers:

  • Lower total cost of ownership with hardware included
  • Open, flexible BLE infrastructure
  • Fast deployment without proprietary antennas
  • AI-enhanced accuracy rivaling UWB
  • A unified platform for hospital safety, indoor navigation, and operational intelligence

“Hospitals Need More Than Location — They Need Intelligence”

“Healthcare systems are reaching a breaking point with outdated RTLS models,” said Mohammed Smadi, CEO of Penguin Location Services. “What they need now is intelligent hospital operations, not just dots on a map. Penguin’s RTLS 3.0 platform replaces complexity with clarity—improving healthcare staff safety, reducing patient delays, and delivering measurable ROI for hospital asset management.”

About Penguin Location Services

Penguin Location Services is an AI and indoor positioning company delivering RTLS 3.0, the next evolution of real-time location intelligence for healthcare. With a proprietary BLE 5.1 platform and a suite of operational intelligence products—including PenTrack™, PenSafe™, and PenNav™—Penguin helps healthcare networks, hospital systems, and medical facilities improve staff safety, patient flow, equipment tracking, and mission-critical operations.

Learn more about Healthcare RTLS solutions and RTLS 3.0 technology at penguinin.com

Penguin Location Services, PenTrack, PenSafe, PenNav, are trademarks of PenguinIN, Inc.

View original content to download multimedia:https://www.prnewswire.com/news-releases/penguin-location-services-announces-breakthrough-rtls-3-0-platform-and-expands-healthcare-ai-capabilities-for-2026–302643411.html

SOURCE Penguin Location Services

Staff

Recent Posts

UOG (United One Group) Wins Three Prestigious Industry Awards at CES 2026

CES Official Spokesperson Highlights UOG Featured ProductsIntroducing the World's First Black Diamond Carbon & Nano…

6 hours ago

Best Ipamorelin vs Sermorelin: Growth Hormone Peptide Comparison 2026 — ReadyRx Prescription Telehealth Analysis

Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth…

9 hours ago

GLP-1 Booster From Health Journey: 2026 Ingredient Analysis And Probiotic Metabolic Support Explained

Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement…

9 hours ago

MEDVi GLP-1 Investigation: What Consumer Data Shows About Compounded Telehealth Weight Loss Programs

Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading…

9 hours ago

Best Peptides for Anti-Aging: NAD+ Delivery Methods Compared as Telehealth Platforms Expand Access (2026 Analysis)

Published NAD+ research examines cellular aging pathways and mitochondrial function as prescription peptide injection access…

9 hours ago

Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026

Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a…

9 hours ago